Alphabet-founded biotech Calico Life Sciences has struck an exclusive licensing agreement with Chinese drugmaker Mabwell (SHA ...

US biotech Arbutus Biopharma (Nasdaq: ABUS) has reacquired the rights to its lead hepatitis B candidate, imdusiran (AB-729), ...

German drugmaker Bayer (BAYN: DE) has renewed its partnership with China’s Tsinghua University for another three years, ...

US biotech major Biogen today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of ...

German biosimilars company Formycon has announced that its 2025/2029 corporate bond was significantly oversubscribed due to ...

Italian drugmaker Philogen has announced its decision to voluntarily withdraw the application for marketing authorization to ...

In a significant showcase for investors, BeOne Medicines announced major advancements to its industry-leading oncology ...

Indian drugmaker Biocon has announced that Health Canada has granted a Notice of Compliance for Yesafili (aflibercept), a ...

Japanese drugmaker Chugai Pharmaceutical today revealed that it has filed a regulatory application with the Ministry of ...

Belgian pharma UCB today announced that the Phase III study investigating the safety and efficacy of adjunctive fenfluramine ...

US pharma major Merck & Co has secured a key endorsement for its newly approved respiratory syncytial virus (RSV) prevention ...

Rising use of innovative medicines and shifting spending patterns are reshaping the global pharmaceutical landscape, ...